TFAP2A facilitates aerobic glycolysis and metastasis of pancreatic cancer via IGF2BP2-mediated LDHA m6A modification

Key Points

• Metastasis is significantly enhanced by TFAP2A activity in pancreatic cancer cells, indicating a crucial role in disease progression.
• Elevated levels of LDHA m6A modification are closely linked to increased glycolytic activity, underscoring metabolic shifts in cancer cells.
• Exploration of IGF2BP2 involvement shows it is vital for TFAP2A's regulatory influence on LDHA, connecting molecular pathways to clinical outcomes.
• Findings suggest potential new strategies for targeting aerobic glycolysis in pancreatic cancer treatments, though further investigation is essential.